Found: 30
Select item for more details and to access through your institution.
Valproic acid as a therapeutic agent for head and neck squamous cell carcinomas.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 381, doi. 10.1007/s00280-008-0747-1
- By:
- Publication type:
- Article
A novel phenotypic method to determine fludarabine triphosphate accumulation in T-lymphocytes from hematopoietic cell transplantation patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 391, doi. 10.1007/s00280-008-0748-0
- By:
- Publication type:
- Article
Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 403, doi. 10.1007/s00280-008-0749-z
- By:
- Publication type:
- Article
Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2′-deoxycytidine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 411, doi. 10.1007/s00280-008-0750-6
- By:
- Publication type:
- Article
Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 417, doi. 10.1007/s00280-008-0751-5
- By:
- Publication type:
- Article
Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 427, doi. 10.1007/s00280-008-0752-4
- By:
- Publication type:
- Article
Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 433, doi. 10.1007/s00280-008-0753-3
- By:
- Publication type:
- Article
Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 441, doi. 10.1007/s00280-008-0754-2
- By:
- Publication type:
- Article
Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin, in resistant solid tumor malignancies.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin<sup>®</sup>, in resistant solid tumor malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 451, doi. 10.1007/s00280-008-0756-0
- By:
- Publication type:
- Article
Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 459, doi. 10.1007/s00280-008-0759-x
- By:
- Publication type:
- Article
A Bayesian population PK-PD model for ispinesib/docetaxel combination-induced myelosuppression.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
A Bayesian population PK–PD model for ispinesib/docetaxel combination-induced myelosuppression.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 469, doi. 10.1007/s00280-008-0760-4
- By:
- Publication type:
- Article
A dose-ranging study of the pharmacokinetics and pharmacodynamics of the selective apoptotic antineoplastic drug (SAAND), OSI-461, in patients with advanced cancer, in the fasted and fed state.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 477, doi. 10.1007/s00280-008-0761-3
- By:
- Publication type:
- Article
ASNA1, an ATPase targeting tail-anchored proteins, regulates melanoma cell growth and sensitivity to cisplatin and arsenite.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 491, doi. 10.1007/s00280-008-0762-2
- By:
- Publication type:
- Article
Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 501, doi. 10.1007/s00280-008-0765-z
- By:
- Publication type:
- Article
Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 509, doi. 10.1007/s00280-008-0768-9
- By:
- Publication type:
- Article
Enterohepatic recirculation model of irinotecan (CPT-11) and metabolite pharmacokinetics in patients with glioma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 517, doi. 10.1007/s00280-008-0769-8
- By:
- Publication type:
- Article
Effect of antacid on imatinib absorption.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 525, doi. 10.1007/s00280-008-0778-7
- By:
- Publication type:
- Article
Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 529, doi. 10.1007/s00280-008-0822-7
- By:
- Publication type:
- Article
Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 535, doi. 10.1007/s00280-008-0836-1
- By:
- Publication type:
- Article
Carbamazepine induces bioactivation of cyclophosphamide and thiotepa.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 543, doi. 10.1007/s00280-008-0758-y
- By:
- Publication type:
- Article
Pathologic complete response after palliative 3rd line chemotherapy with capecitabine alone in metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 549, doi. 10.1007/s00280-008-0766-y
- By:
- Publication type:
- Article
Detection of complete response to imatinib mesylate (Glivec/Gleevec) with 18F-FDG PET/CT for low-grade endometrial stromal sarcoma.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Detection of complete response to imatinib mesylate (Glivec<sup>®</sup>/Gleevec<sup>®</sup>) with 18F-FDG PET/CT for low-grade endometrial stromal sarcoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 555, doi. 10.1007/s00280-008-0786-7
- By:
- Publication type:
- Article
Detection of complete response to imatinib mesylate (Glivec<sup>®</sup>/Gleevec<sup>®</sup>) with 18F-FDG PET/CT for low-grade endometrial stromal sarcoma.
- Published in:
- 2009
- By:
- Publication type:
- Correction notice
Pharmacokinetic profile of imatinib mesylate and N-desmethyl-imatinib (CGP 74588) in children with newly diagnosed Ph+ acute leukemias.
- Published in:
- 2009
- By:
- Publication type:
- Letter
MDA-MB-435 cells are from melanoma, not from breast cancer.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand.
- Published in:
- 2009
- By:
- Publication type:
- Correction notice